Mycosis Fungoides Clinical Trials in Houston, Texas
8 recruitingHouston, Texas
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Recurrent Mycosis FungoidesRefractory Mycosis FungoidesSezary Syndrome+5 more
City of Hope Medical Center78 enrolled4 locationsNCT03011814
Recruiting
A Registry for People With T-cell Lymphoma
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Phase 2
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
Mycosis FungoidesLocalized Skin Lesion
M.D. Anderson Cancer Center50 enrolled1 locationNCT03398161
Recruiting
Phase 3
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Mycosis FungoidesCutaneous T Cell LymphomaCTCL+1 more
Soligenix80 enrolled17 locationsNCT06470451
Recruiting
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Mycosis FungoidesLymphomatoid Papulosis
M.D. Anderson Cancer Center100 enrolled1 locationNCT06207812
Recruiting
Phase 2
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Mycosis Fungoides
M.D. Anderson Cancer Center30 enrolled1 locationNCT05357794
Recruiting
Phase 1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell LymphomaPeripheral T Cell LymphomaMycosis Fungoides+8 more
SciTech Development, Inc.46 enrolled10 locationsNCT04234048
Recruiting
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Recurrent Mycosis FungoidesRecurrent Sezary SyndromeRefractory Mycosis Fungoides+6 more
City of Hope Medical Center100 enrolled10 locationsNCT07003100